{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T20:20:33Z","timestamp":1786393233133,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2012 National Research Program"],"award-info":[{"award-number":["PRIN 2012 National Research Program"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Prot. 20122EK9SZ"],"award-info":[{"award-number":["Prot. 20122EK9SZ"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders caused by the deficit of lysosomal hydrolases involved in the degradation of glycosaminoglycans (GAGs). The course is chronic and progressive, with multisystemic involvement that often leads to cardiovascular disease. We describe the overall incidence and type of cardiac damage in a cohort of Italian MPS patients, and their progression over time, also with reference to treatment efficacy in patients under Enzyme Replacement Therapy (ERT). Moreover, we report a possible association between genetic variants and cardiac phenotype in homozygous and hemizygous patients to understand whether a more aggressive clinical phenotype would predict a greater cardiac damage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our findings confirm that cardiac involvement is very common, already at diagnosis, in MPS VI (85.7% of our cohort), and in MPS II (68% of our cohort) followed by MPS I subjects (55% of our cohort). The most frequent heart defect observed in each MPS and at any time-point of evaluation was mitral insufficiency; 37% of our patients had mitral insufficiency already at diagnosis, and 60% at post-ERT follow-up. After at least six years of treatment, we observed in some cases (including 6 MPS II, 2 MPS IV and 2 MPS VI) a total regression or improvement of some signs of the cardiac pathology, including some valve defects, though excluding aortic insufficiency, the only valvulopathy for which no regression was found despite ERT. The general clinical phenotype proved not to be strictly correlated with the cardiac one, in fact in some cases patients with an attenuated phenotype developed more severe heart damage than patients with severe phenotype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In conclusion, our analysis confirms the wide presence of cardiopathies, at different extent, in the MPS population. Since cardiac pathology is the main cause of death in many MPS subtypes, it is necessary to raise awareness among cardiologists about early cardiac morpho-structural abnormalities. The encouraging data regarding the long-term effects of ERT, also on heart damage, underlines the importance of an early diagnosis and timely start of ERT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02396-5","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:04:58Z","timestamp":1656507898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study"],"prefix":"10.1186","volume":"17","author":[{"given":"Simona","family":"Sestito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Rinninella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Rampazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D\u2019Avanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Zampini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Fiumara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Tomanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1223-7358","authenticated-orcid":false,"given":"Daniela","family":"Concolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2396_CR1","unstructured":"Salvatrici E, Giovannini M, Cefalo G, Paci S, Riva E, Banderali G. Errori congeniti del metabolismo. In: Scriver G.V.Zuccotti, Manuale di pediatria. La pratica clinica. 2a edizione. Bologna, BO, Italia: Esculapio, 2016."},{"issue":"4","key":"2396_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ymgme.2016.02.003","volume":"117","author":"HY Lin","year":"2016","unstructured":"Lin HY, Chuang CK, Chen MR, Lin SM, Hung CL, Chang CY, et al. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II IVA and VI. Mol Genet Metab. 2016;117(4):431\u20137.","journal-title":"Mol Genet Metab"},{"issue":"01","key":"2396_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1055\/s-0036-1582252","volume":"06","author":"F Falvo","year":"2016","unstructured":"Falvo F, Sestito S, Nicoletti A, Grisolia M, Mascaro I, Pascale E, et al. The different forms of mucopolysaccharidosis with neurological involvement: a case-based review. J Pediatr Biochem. 2016;06(01):46\u201352.","journal-title":"J Pediatr Biochem"},{"issue":"01","key":"2396_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0036-1582224","volume":"06","author":"S Sestito","year":"2016","unstructured":"Sestito S, Ceravolo F, Falvo F, Nicoletti A, Stefanelli E, Apa R, et al. Pathobiological insights into the newly targeted therapies of lysosomal storage disorders. J Pediatr Biochem. 2016;06(01):30\u20138.","journal-title":"J Pediatr Biochem"},{"issue":"7","key":"2396_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","volume":"14","author":"E Piotrowska","year":"2006","unstructured":"Piotrowska E, Jak\u00f3bkiewicz-Banecka J, Bara\u0144ska S, Tylki-Szyma\u0144ska A, Czartoryska B, Wegrzyn A, et al. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet. 2006;14(7):846\u201352.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"2396_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1476-5381.2009.00565.x","volume":"159","author":"A Friso","year":"2010","unstructured":"Friso A, Tomanin R, Salvalaio M, Scarpa M. Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. Br J Pharmacol. 2010;159(5):1082\u201391.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2396_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/iub.1007","volume":"64","author":"A W\u0119grzyn","year":"2012","unstructured":"W\u0119grzyn A. Gene expression-targeted isoflavone therapy. IUBMB Life. 2012;64(4):307\u201315.","journal-title":"IUBMB Life"},{"key":"2396_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-014-0129-1","volume":"9","author":"R Tomanin","year":"2014","unstructured":"Tomanin R, Zanetti A, D\u2019Avanzo F, Rampazzo A, Gasparotto N, Parini R, et al. Clinical efficacy of enzyme replacement therapy in paediatric Hunter patients, an independent study of 3.5 years. Orphanet J Rare Dis. 2014;9:129.","journal-title":"Orphanet J Rare Dis"},{"key":"2396_CR9","unstructured":"Sestito S, Ceravolo F, Grisolia M, Pascale E, Pensabene L, Concolino D. Profile of idursulfase for the treatment of Hunter syndrome. Research and Reports in Endocrine Disorders, 2015;2015:579\u201390."},{"issue":"39","key":"2396_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1824-7288-39-53","volume":"9","author":"F Ceravolo","year":"2013","unstructured":"Ceravolo F, Mascaro I, Sestito S, Pascale E, Lauricella A, Dizione E, et al. Home treatment in paediatric patients with Hunter syndrome: the first Italian experience. Ital J Pediatr. 2013;9(39):53.","journal-title":"Ital J Pediatr"},{"issue":"7","key":"2396_CR11","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","volume":"25","author":"M Taylor","year":"2019","unstructured":"Taylor M, Khan S, Stapleton M, Wang J, Chen J, Wynn R, et al. Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future. Biol Blood Marrow Transplant. 2019;25(7):e226\u201346.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2396_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1365-2141.2009.07974.x","volume":"148","author":"VK Prasad","year":"2010","unstructured":"Prasad VK, Kurtzberg J. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions. Br J Haematol. 2010;148(3):356\u201372.","journal-title":"Br J Haematol"},{"key":"2396_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1172-6-55","volume":"6","author":"MH De Ru","year":"2011","unstructured":"De Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, et al. Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis. 2011;6:55.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"2396_CR14","first-page":"152","volume":"12","author":"R Giugliani","year":"2014","unstructured":"Giugliani R, Herber S, Lapagesse L, de Pinto C, Baldo G. Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospects. Pediatr Endocrinol Rev. 2014;12(Suppl 1):152\u20138.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"2396_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1566523218666180404155759","volume":"18","author":"S Sestito","year":"2018","unstructured":"Sestito S, Falvo F, Scozzafava C, Apa R, Pensabene L, Bonapace G, et al. Genetics and gene therapy in hunter disease. Curr Gene Ther. 2018;18(2):90\u20135.","journal-title":"Curr Gene Ther"},{"issue":"9","key":"2396_CR16","first-page":"638","volume":"18","author":"P Russo","year":"2017","unstructured":"Russo P, Andria G, Baldinelli A, Boffi ML, Cerini E, Della Casa R, et al. Cardiologists and mucopolysaccharidoses. Recommendations of GICEM (Cardiology Experts on Metabolic Disease Italian Group) for diagnosis, follow-up and cardiological management. G Ital Cardiol Rome. 2017;18(9):638\u201349.","journal-title":"G Ital Cardiol Rome"},{"issue":"4 Suppl. 2","key":"2396_CR17","first-page":"107","volume":"34","author":"S Sestito","year":"2020","unstructured":"Sestito S, Parisi F, Tallarico V, Tarsitano F, Roppa K, Pensabene L, et al. Cardiac involvement in lysosomal storage diseases. J Biol Regul Homeost Agents Jul-Aug. 2020;34(4 Suppl. 2):107\u201319.","journal-title":"J Biol Regul Homeost Agents Jul-Aug"},{"key":"2396_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1017\/S104795110999062X","volume":"20","author":"GN Leal","year":"2010","unstructured":"Leal GN, de Paula AC, Leone C, Kim CA. Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol Young. 2010;20:254\u201361.","journal-title":"Cardiol Young"},{"key":"2396_CR19","first-page":"59","volume":"15","author":"C Lavery","year":"2015","unstructured":"Lavery C, Hendriksz C. Mortality in patients with Morquio syndrome A. JIMD Rep. 2015;15:59\u201366.","journal-title":"JIMD Rep"},{"issue":"5","key":"2396_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00431-019-03341-8","volume":"178","author":"A Zanetti","year":"2019","unstructured":"Zanetti A, D\u2019Avanzo F, Rigon L, Rampazzo A, Concolino D, Barone R, et al. Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study. Eur J Pediatr. 2019;178(5):739\u201353.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2396_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/hum.2014.109","volume":"26","author":"R Ferla","year":"2015","unstructured":"Ferla R, Claudiani P, Savarese M, Kozarsky K, Parini R, Scarpa M, et al. Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial. Hum Gene Ther. 2015;26(3):145\u201352.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"2396_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1034\/j.1399-0004.2001.600412.x","volume":"60","author":"I Moreira da Silva","year":"2001","unstructured":"Moreira da Silva I, Froissart R, Marques dos Santos H, Caseiro C, Maire I, Bozon D. Molecular basis of mucopolysaccharidosis type II in Portugal: identification of four novel mutations. Clin Genet. 2001;60(4):316\u20138.","journal-title":"Clin Genet"},{"issue":"1","key":"2396_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ymgme.2006.07.014","volume":"90","author":"CE Beesley","year":"2007","unstructured":"Beesley CE, Concolino D, Filocamo M, Winchester BG, Strisciuglio P. Identification and characterisation of an 8.7 kb deletion and a novel nonsense mutation in two Italian families with Sanfilippo syndrome type D (mucopolysaccharidosis IIID). Mol Genet Metab. 2007;90(1):77\u201380.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"2396_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymgmr.2015.10.014","volume":"8","author":"Y Sato","year":"2015","unstructured":"Sato Y, Fujiwara M, Kobayashi H, Yoshitake M, Hashimoto K, Oto Y, et al. Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy. Mol Genet Metab Rep. 2015;8(5):94\u20137.","journal-title":"Mol Genet Metab Rep"},{"issue":"60","key":"2396_CR25","doi-asserted-by":"publisher","first-page":"60ra89","DOI":"10.1126\/scitranslmed.3001380","volume":"2","author":"AD Dierenfeld","year":"2010","unstructured":"Dierenfeld AD, McEntee MF, Vogler CA, Vite CH, Chen AH, Passage M, et al. Replacing the enzyme \u03b1-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I. Sci Transl Med. 2010;2(60):60ra89.","journal-title":"Sci Transl Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02396-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:09:25Z","timestamp":1656508165000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02396-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2396"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02396-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving humans performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients gave informed consent to use their anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}